Mid-weight oncology stocks: The dark horses of cancer research
18 No. of Symbols
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.7050 USD
−142.66 M USD
0.00 USD
66.21 M
About Adicet Bio, Inc.
Sector
CEO
Chen Schor
Headquarters
Boston
Website
Founded
2014
FIGI
BBG00JCXSJP3
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ACET is featured.
Frequently Asked Questions
The current price of ACET is 0.9000 USD — it has decreased by −1.53% in the past 24 hours. Watch Adicet Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Adicet Bio, Inc. stocks are traded under the ticker ACET.
ACET stock has fallen by −10.89% compared to the previous week, the month change is a −40.00% fall, over the last year Adicet Bio, Inc. has showed a −21.05% decrease.
We've gathered analysts' opinions on Adicet Bio, Inc. future price: according to them, ACET price has a max estimate of 8.00 USD and a min estimate of 4.00 USD. Watch ACET chart and read a more detailed Adicet Bio, Inc. stock forecast: see what analysts think of Adicet Bio, Inc. and suggest that you do with its stocks.
ACET reached its all-time high on Feb 26, 2018 with the price of 147.6818 USD, and its all-time low was 0.9300 USD and was reached on Nov 15, 2024. View more price dynamics on ACET chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ACET stock is 7.22% volatile and has beta coefficient of 1.41. Track Adicet Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Adicet Bio, Inc. there?
Today Adicet Bio, Inc. has the market capitalization of 74.16 M, it has decreased by −3.47% over the last week.
Yes, you can track Adicet Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Adicet Bio, Inc. is going to release the next earnings report on Mar 12, 2025. Keep track of upcoming events with our Earnings Calendar.
ACET earnings for the last quarter are −0.34 USD per share, whereas the estimation was −0.34 USD resulting in a 0.15% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Adicet Bio, Inc. earnings.
Adicet Bio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ACET net income for the last quarter is −30.48 M USD, while the quarter before that showed −29.90 M USD of net income which accounts for −1.93% change. Track more Adicet Bio, Inc. financial stats to get the full picture.
No, ACET doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 143.00 employees. See our rating of the largest employees — is Adicet Bio, Inc. on this list?
Like other stocks, ACET shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Adicet Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Adicet Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Adicet Bio, Inc. stock shows the sell signal. See more of Adicet Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.